Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Philippines Pharmaceutical Market Value to Reach $8 Billion by 2020

May 27, 2014

The Philippines pharmaceutical market value is expected to increase from approximately $4.3 billion in 2013 to $8 billion by 2020.

Avantor Performance Materials Names New CEO

May 27, 2014

Avantor Performance Materials appoints Michael Stubblefield as CEO.

FDA Targets Illegal Online Pharmacies

May 27, 2014

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

GSK Announces Vaccine Price Freeze in Support of GAVI Alliance

May 27, 2014

GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.

GE Healthcare Launches Xuri IL-2 Growth Factor

May 23, 2014

GE Healthcare launches the Xuri IL-2 for the activation and expansion of T-lymphocytes.

Selexys Pharmaceuticals Signs CMO Agreement with Cytovance Biologics

May 22, 2014

Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.

More Than 100 New Medicines in Development to Treat Mental Health Disorders

May 22, 2014

PhRMA announces 119 new medicines are in development to treat mental and addictive disorders.

Brookfield Marks 80 Years of Laboratory Technology

May 22, 2014

Brookfield continues to supply viscometers and rheometers for laboratory and on-line process control applications.

Kymab Receives $40 Million Investment From Gates Foundation and Wellcome Trust

May 22, 2014

Kymab receives $40 million investment for clinical development of antibody therapeutics.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here